Cargando…

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2

Detalles Bibliográficos
Autores principales: Bizouarne, N, Squiban, P, Acres, B, Balloul, JM, Ohresser, MA, Figlin, R, Belldegrun, A, Herrman, R, Rochlitz, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300517/
http://dx.doi.org/10.1186/bcr334
_version_ 1782226297025462272
author Bizouarne, N
Squiban, P
Acres, B
Balloul, JM
Ohresser, MA
Figlin, R
Belldegrun, A
Herrman, R
Rochlitz, C
author_facet Bizouarne, N
Squiban, P
Acres, B
Balloul, JM
Ohresser, MA
Figlin, R
Belldegrun, A
Herrman, R
Rochlitz, C
author_sort Bizouarne, N
collection PubMed
description
format Online
Article
Text
id pubmed-3300517
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33005172012-03-14 Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2 Bizouarne, N Squiban, P Acres, B Balloul, JM Ohresser, MA Figlin, R Belldegrun, A Herrman, R Rochlitz, C Breast Cancer Res Meeting Abstract BioMed Central 2001 2001-05-29 /pmc/articles/PMC3300517/ http://dx.doi.org/10.1186/bcr334 Text en Copyright ©2001 BioMed Central Ltd
spellingShingle Meeting Abstract
Bizouarne, N
Squiban, P
Acres, B
Balloul, JM
Ohresser, MA
Figlin, R
Belldegrun, A
Herrman, R
Rochlitz, C
Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
title Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
title_full Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
title_fullStr Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
title_full_unstemmed Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
title_short Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
title_sort specific immunotherapy of muc1-positive adenocarcinomas with a recombinant vaccinia virus expressing muc1 and il-2
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300517/
http://dx.doi.org/10.1186/bcr334
work_keys_str_mv AT bizouarnen specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT squibanp specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT acresb specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT ballouljm specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT ohresserma specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT figlinr specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT belldegruna specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT herrmanr specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2
AT rochlitzc specificimmunotherapyofmuc1positiveadenocarcinomaswitharecombinantvacciniavirusexpressingmuc1andil2